Drug development is expensive and risky. But what if there was a way to make it more appealing to investors? A new idea is on the table. It's about testing many drugs at once. This way, investors can put their money into a group of potential treatments instead of just one. Here's how it works. Investors chip in to cover part of the trial costs. In return, they get a...